Drug Profile
Aciclovir-PMPA
Alternative Names: ACVpPMPALatest Information Update: 03 Sep 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections; HIV-1 infections
Most Recent Events
- 03 Sep 2001 No-Development-Reported for Herpes simplex virus infections in Italy (Unknown route)
- 03 Sep 2001 No-Development-Reported for HIV-1 infections in Italy (Unknown route)
- 29 Sep 1998 New profile